Showing results (1271-1280 of 9,543) with videos related to

Sort By:
Pageof 955
Microbiology Spectrum|November 11, 2025
Evaluating the susceptibility of various common cell lines and assessing inactivation conditions to Mpox virusShu-Chen Hsu, Ping-Cheng Liu, Shan-Ko Tsai, et al.
Microbiology Spectrum|October 22, 2025
Role of antifungal drugs in modulating interaction between Candida glabrata and macrophages: cytokine profiles and TEM analysisXinyi Wang, Zhenghui Yang, Yuye Li, et al.
Microbiology Spectrum|October 8, 2025
In vitro activity of cefiderocol against nosocomial Acinetobacter baumanniiBarbara Ymaña, Rocío Egoávil-Espejo, Rosario Huerto-Huánuco, et al.
Microbiology Spectrum|October 6, 2025
Urine PCR testing as an effective method for early diagnosis of leptospirosisPaul Le Turnier, Mathilde Zenou, Mathieu Nacher, et al.
Microbiology Spectrum|October 20, 2025
Pangenome analysis of Tanzanian clinical Klebsiella pneumoniae reveals pandemic clones with high genome plasticity and versatile mobilome, virulome, and resistome profilesSamweli Y Bahati, Reuben S Maghembe
Microbiology Spectrum|October 20, 2025
Stage-specific vaginal microbial alterations in pregnancy-associated vulvovaginal candidiasisZhe Li, Yiwen Zhang, Xiujie Li, et al.
Microbiology Spectrum|October 20, 2025
Genomic insights and functional adaptation of Mycobacterium intracellulare strains isolated from patients with inflammatory bowel diseaseSushanta Deb, Lata Kumari, Neeraj Mahajan, et al.
Microbiology Spectrum|October 20, 2025
In vitro modeling of the female gut microbiome: effects of sex hormones and psychotropic drugsLuana Leao, Galal Ali Esmail, Saba Miri, et al.
Microbiology Spectrum|October 20, 2025
Two strains of Bacillus velezensis: potent probiotics against Escherichia coli K99-induced diarrhea with high safety in miceFengjie Wang, Yanan Wang, Hongjun Zhang, et al.
Microbiology Spectrum|October 13, 2025
Activity of cefiderocol against Pseudomonas aeruginosa from the USA and Europe (2020-2023) with difficult-to-treat resistance phenotype, including those nonsusceptible to recently developed β-lactam/β-lactamase inhibitor combinations: results from the SENTRY antimicrobial surveillance programJohn H Kimbrough, Maura H Karr, Sean T Nguyen, et al.
Pageof 955